A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT07046780 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07046780
Sponsor: PENG YUAN
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Solid Tumor Cancer Metastatic Solid Tumors Locally Advanced

Start date: 2025-07-30
Primary completion: 2027-07-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.